September 6, 2019

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

Researchers find alarming risk for people coming off chronic opioid prescriptions

Credit: CC0 Public Domain
× close
Credit: CC0 Public Domain

With a huge push to reduce opioid prescribing, little is known about the real-world benefits or risks to patients.

A recent study published in the Journal of General Internal Medicine found an alarming outcome: Patients coming off opioids for pain were three times more likely to die of an overdose in the years that followed.

"We are worried by these results, because they suggest that the intended to make prescribing safer are not working as intended," said lead author Jocelyn James, assistant professor of general internal medicine at the University of Washington School of Medicine. "We have to make sure we develop systems to protect patients."

Physicians had already begun to reduce opioid prescribing by 2016, when the CDC issued its first guideline on opioid prescribing. That trend accelerated after 2016.

While reduced prescribing may well be intended to improve , little is known about the real world benefits or risks of this sea change in opioid prescribing.

The study looked at a cohort of 572 patients with enrolled in an opioid registry. Chronic opioid therapy was discontinued in 344 patients and 187 continued to visit a primary care clinic. During the study period, 119 registry patients died (20.8%); 21 patients died of a definitive or possible overdose—17 were discontinued patients and four were patients being seen at a clinic.

As the researchers concluded: "Discontinuing chronic opioid therapy was associated with increased risk of death."

Researchers said that improved clinical strategies, including multimodal pain management and treatment of opioid-use disorder, may be needed for this high-risk group.

At the time of this study, state rules did not allow medication treatment of opioid-use disorder in the primary care setting, said co-author Joseph Merrill, professor of general internal medicine at the University of Washington School of Medicine.

But after those rules changed, he said the addiction clinic at Harborview has developed a strong program to provide medication treatment for opioid-use disorder, including those who develop problems related to prescription pain medication.

"We hope these findings encourage others who prescribe opioids to do the same," Merrill said.

Researchers said the UW Medicine study is the third study published this year to look at the risks of stopping opioids:

More information: Jocelyn R. James et al, Mortality After Discontinuation of Primary Care–Based Chronic Opioid Therapy for Pain: a Retrospective Cohort Study, Journal of General Internal Medicine (2019). DOI: 10.1007/s11606-019-05301-2

Journal information: Journal of General Internal Medicine

Load comments (0)